Clinical Trials · NCT07104487
[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 24
- Start date
- Mar 2025
- Locations
- 1 site, Belgium
- Primary endpoint
- Quantification of ICA [18F]AlF-OC uptake